reviewNature Reviews Drug DiscoverySep 2, 2010Closed access

Development trends for human monoclonal antibody therapeutics

Tufts University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,025
total citations
FWCI
71.27
Percentile
100%
References
62
Citations per year

Authors

3

Topics & keywords

Keywords
  • Medicine
  • Belimumab
  • Monoclonal antibody
  • Biosimilar
  • Canakinumab
  • Drug development
  • Panitumumab
  • Ixekizumab
No related works found for this paper.